% Expired Patents = 85.7

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 12

Loading Chart...

2 inventors (with patents filed for the assignee):

Neil M Bodie (7 out of 8 patents)

Elliot Altman (6 out of 24 patents)

Renee Bodie (0 patent)

4. Renee Bodie (0 patent)

7 patents: Sort by Forward Citations

1. 10179803 - Methods for inhibiting immune complex formation in a subject (2019-01-15),

2. 9447145 - Compositions for inhibiting immune complex formation in a subject (2016-09-20),

3. 8815813 - Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome (2014-08-26),

4. 8362202 - Methods for inhibiting immune complex formation in a subject (2013-01-29),

5. 7786258 - Methods for inhibiting immune complex formation in a subject (2010-08-31),

6. 7714104 - Methods for inhibiting immune complex formation in a subject (2010-05-11),

7. 7584059 - Inhibition of immune complex formation (2009-09-01),

Company Overview

Trinity Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for various diseases. With a focus on personalized medicine, we strive to provide targeted treatments that improve patient outcomes. Our team of experts is committed to advancing research and delivering cutting-edge solutions to address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#8 in Agoura Hills, CA

#9,501 in California

#39,907 in US

Agoura Hills, CA, United States of America

Trinity Therapeutics, Inc.

Forward Citations = 12

2 inventors:

Neil M Bodie (7 out of 8 patents)

Elliot Altman (6 out of 24 patents)

Renee Bodie (0 patent)

4. Renee Bodie (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trinity Therapeutics, Inc.. Retrieved from https://idiyas.com/company/trinity-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]